Skip to Main Content


Skip Nav Destination

Recombinant Humanized Anti-HER2 Antibody (Herceptin™) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts1

Cancer Res (1998) 58 (13): 2825–2831.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal